Sage Therapeutics Inc
NASDAQ:SAGE 4:00:00 PM EDT
| Market Cap (Intraday) | 571.10M |
| Current PE | N/A |
| Forward PE | N/A |
| 2yr Forward PE | N/A |
| 10-Day MA | $8.86 |
| 50-Day MA | $7.40 |
| 200-Day MA | $6.98 |
Sage Therapeutics Inc Stock, NASDAQ:SAGE
55 Cambridge Parkway, Cambridge, Massachusetts 02142
United States of America
Phone: +1.617.299.8380
Number of Employees: 353
Description
SAGE Therapeutics, Inc. is a biopharmaceutical company, which engages in providing solutions to brain health medicines. It focuses on diseases and disorders of the brain. Its products include ZURZUVAE and ZULRESSO. The company was founded by Steven Marc Paul and Douglas Covey on April 16, 2010 and is headquartered in Cambridge, MA.